DiaMedica Therapeutics, Inc.
DiaMedica-Logo
Navigate DiaMedica Therapeutics, Inc.
Home
About Us
Company Overview
Leadership Team
Board of Directors
Clinical Advisory Boards
Science
Our Science
Pipeline
Diseases We Target
Overview
IgA Nephropathy
African Americans - Hypertensive with CKD
Acute Ischemic Stroke
Investors & Media
Investors Home
Press Releases
Events & Presentations
Nasdaq Stock Information
Analyst Coverage
Financial Reports
Governance
Investor Resources
Careers
Contact
Home
Investors & Media
Press Releases
Press Releases
All News
By Year:
2021
2020
2019
2018
2017
2016
Aug 10, 2020
DiaMedica Announces Closing of $23 Million Public Offering of Common Shares
Aug 6, 2020
DiaMedica Therapeutics to Report Second Quarter 2020 Financials and Provide a Business Update August 12, 2020
Aug 6, 2020
DiaMedica Announces Pricing of $20 Million Public Offering of Common Shares
Aug 5, 2020
DiaMedica Announces Proposed Public Offering of Common Shares
May 19, 2020
DiaMedica Therapeutics to Present at the 17th Annual Craig-Hallum Institutional Investor Conference on May 27, 2020
May 13, 2020
DiaMedica Announces Positive Results in Top-Line Data From the Phase II ReMEDy Acute Ischemic Stroke Study
May 13, 2020
DiaMedica Announces Positive Results in Top-Line Data from the Phase II ReMEDy Acute Ischemic Stroke Study and Provides a Business Update and First Quarter 2020 Financial Results
May 7, 2020
DiaMedica Therapeutics to Report First Quarter 2020 Financial Results and Provide a Business Update May 14, 2020
Mar 26, 2020
DiaMedica Therapeutics to Present Research at National Kidney Foundation 2020 Spring Clinical Meetings Live Virtual Conference
Mar 23, 2020
DiaMedica Therapeutics Announces 2019 Financial Results and Provides Business Update
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>
Show All